Skip to main content
. 2004 Nov;48(11):4286–4292. doi: 10.1128/AAC.48.11.4286-4292.2004

FIG. 3.

FIG. 3.

In vitro stimulation of PBMCs with trypomastigote antigen before, during, and 6 months after treatment from dogs infected with the Y and the Berenice-78 T. cruzi strains for the control group and dogs treated with 1.5 mg of albaconazole per kg of body weight for 60 (A) and 90 (B) days or 7 mg of benznidazole per kg divided into two daily doses for 60 days. IC, infected nontreated controls; UC, uninfected controls; BzT−, dogs treated with benznidazole with negative hemoculture and PCR test results; ALB+, dogs treated with albaconazole with positive hemoculture and PCR test results; ALB−, treated with albaconazole with negative hemoculture and PCR test results. Data represent means ± standard deviations.